Public Offering
Search documents
Datacentrex Announces Pricing of $20.17 Million Confidentially Marketed Public Offering at $2.00 per Share
Globenewswire· 2026-03-26 21:43
SALT LAKE CITY, March 26, 2026 (GLOBE NEWSWIRE) -- Datacentrex, Inc. (Nasdaq: DTCX) (“Datacentrex” or the “Company”), a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses, today announced the pricing of its confidentially marketed public offering (the "Offering") of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common st ...
Datacentrex Announces Proposed Public Offering
Globenewswire· 2026-03-26 20:05
SALT LAKE CITY, March 26, 2026 (GLOBE NEWSWIRE) -- Datacentrex, Inc. (Nasdaq: DTCX) (“Datacentrex” or the “Company”), a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses, today announced that it has commenced a public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. The Company inten ...
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock
Globenewswire· 2026-03-26 20:01
WALTHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that it has commenced underwritten public offerings of its convertible senior notes due 2032 (the “Convertible Notes” and such offering, the “Convertible Notes Offering ...
Great Pacific Gold Announces Public Offering to Raise up to $15 Million
Globenewswire· 2026-03-25 20:00
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Great Pacific Gold Corp. (“Great Pacific Gold” or the “Company”) (TSXV: GPAC | OTCQX: GPGCF | Germany: 0B3) is pleased to announce that it has entered into an agreement with Haywood Securities Inc., on behalf of a syndicate of agents (collectively, the "Agents"), in connection with a commercially reasonable efforts, public offering of up to 32,000 ...
Forgent Power Solutions Announces Public Offering of Class A Common Stock
Businesswire· 2026-03-24 21:45
Forgent Power Solutions Announces Public Offering of Class A Common Stock Forgent Power Solutions Announces Public Offering of Class A Common Stock Share DAYTON, Minn.--(BUSINESS WIRE)--Forgent Power Solutions, Inc. (NYSE: FPS) ("Forgent†or the "Company†), a leading designer and manufacturer of electrical distribution equipment used in data centers, the power grid and energy-intensive industrial facilities, today announced a public offering of its Class A common stock. The offering consists of 20,688,335 ...
Outlook Therapeutics Announces Proposed Public Offering
Globenewswire· 2026-03-23 21:30
ISELIN, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced a best-efforts public offering of its common stock (or pre-funded warrants in lieu thereof) and accompanying warrants exercisable for shares of its common stock. The offering is subject to market and other conditions and there can be no assurance as to wheth ...
Linkers Industries Announces Pricing of $16 Million Best Efforts Public Offering
Globenewswire· 2026-03-23 13:24
Core Viewpoint - Linkers Industries Limited has announced a public offering expected to generate approximately $16 million in gross proceeds, which will be utilized for acquisitions and operational purposes [1][4]. Group 1: Offering Details - The offering consists of 23,088,023 units, each unit comprising one Class A ordinary share or a pre-funded warrant, along with Series A and Series B Warrants [2]. - The purchase price for each unit is set at $0.693, while the pre-funded unit price is slightly lower at $0.693 minus $0.00001 [3]. - The Series A Warrants have an initial exercise price of $0.7277 and will expire one year after issuance, while the Series B Warrants have an exercise price of $1.1781 and will also expire one year after issuance [2]. Group 2: Use of Proceeds - A portion of the net proceeds from the offering will be allocated to finance the potential acquisition of additional equity interests in LPW Electronics Co Ltd, where the company currently holds a 20% stake [4]. - The remaining funds will be used for capital expenditures, operational capacity, working capital, general corporate purposes, and potential future business combinations or acquisitions [4]. Group 3: Company Background - Linkers Industries Limited specializes in manufacturing and supplying wire and cable harnesses, with over 20 years of experience in the industry [8]. - The company serves global brand name manufacturers and original equipment manufacturers primarily in the home appliances, industrial products, and automotive sectors, focusing on the Asia Pacific region [8].
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
Globenewswire· 2026-03-23 12:00
CUPERTINO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced the closing on March 20, 2026 of its previously announced public offering with healthcare focused institutional investors for the purchase and sale of 6,666,667 shares of it ...
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
Globenewswire· 2026-03-19 20:01
MIAMI, March 19, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the closing of an underwritten public offering of 19,324,677 shares of its common stock at a public offering price of $3.85 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 2,753,246 shares of common ...
Innovation Beverage Group Limited Announces Pricing of $6 Million Public Offering
Globenewswire· 2026-03-13 13:05
Company Overview - Innovation Beverage Group Limited (IBG) is an innovative developer, manufacturer, and marketer of a beverage portfolio consisting of 60 formulations across 13 alcoholic and non-alcoholic brands [6] - The company focuses on premium and super premium brands, aiming to disrupt established market leaders, with its most successful brand being Australian Bitters [6] - IBG was established in 2018 and is headquartered in Sydney, Australia, with a U.S. sales office in California [6] Public Offering Details - The company announced a public offering with expected gross proceeds of approximately $6 million, before deducting fees and expenses [1][3] - The offering consists of 3,428,569 Common Units, each including one Ordinary Share or one Pre-Funded Warrant, and two types of Series Registered Common Warrants, all priced at $1.75 per unit [2] - The transaction is expected to close on or about March 16, 2026, subject to customary closing conditions [3] Use of Proceeds - The company plans to allocate $2,500,000 of the net proceeds to provide a non-interest bearing loan to Blockfuel for exercising its call right under a previous Securities Purchase Agreement [3] - The remaining net proceeds will be used for general corporate purposes and working capital [3] Legal and Regulatory Information - Aegis Capital Corp. is acting as the exclusive placement agent for the offering, with legal counsel provided by Sichenzia Ross Ference Carmel LLP and Kaufman & Canoles, P.C. [4] - A registration statement on Form F-1 was filed with the U.S. Securities and Exchange Commission and declared effective on March 12, 2026 [4]